Neuroradiology: Page 170

PiB-PET finds exercise reduces Alzheimer's risk
By AuntMinnie.com staff writers
PET imaging with carbon-11-labeled Pittsburgh Compound B (PiB) has shown that a sedentary lifestyle is associated with greater cerebral amyloid deposition among cognitively normal individuals with the ε4 allele of the apolipoprotein E gene, according to a report published online January 9 in Archives of Neurology.
January 8, 2012
MRI suggests Copaxone helps MS patients
By AuntMinnie.com staff writers
Teva Neuroscience is touting the results of a study that used an advanced MRI technique to show the benefits of its Copaxone (glatiramer acetate injection) treatment for reducing the frequency of relapses in multiple sclerosis (MS) patients.
January 4, 2012
MRI helps link silent strokes to memory loss
By Wayne Forrest
Research using MRI indicates that small areas of dead brain cells, or silent strokes, found in approximately one of four older adults are linked to memory loss later in life, according to a new study published in the January 3 issue of Neurology.
January 3, 2012
Functional MRI shows how marijuana affects brain processing
By Wayne Forrest
Functional MR images have revealed how different ingredients in marijuana appear to affect regions of the brain as it processes functions and responses to certain visual stimuli and tasks, according to a study in the January issue of Archives of General Psychiatry.
January 2, 2012
MRI biomarker may predict early Alzheimer's disease
By Wayne Forrest
With the help of an MRI biomarker, researchers have found that people with smaller regions of the brain's cortex may be more likely to develop symptoms consistent with early Alzheimer's disease, even if they currently have no memory problems.
December 20, 2011
4.7T MRI tracks brain iron to monitor MS
By AuntMinnie.com staff writers
Researchers at the University of Alberta in Canada are using 4.7-tesla MRI to track the progression of multiple sclerosis (MS) in people with the disease based on increasing levels of iron found in their brain tissue.
December 18, 2011
FDA OKs handheld skull scanning device
By AuntMinnie.com staff writers
InfraScan has received 510(k) clearance from the U.S. Food and Drug Administration to market its handheld Infrascanner Model 1000 near-infrared spectroscopy device, designed to detect bleeding in the skull.
December 13, 2011
Size matters: iPad tops iPhone for evaluating acute stroke
By Erik L. Ridley
Both the iPhone 4 and iPad 2 can be employed by on-call neuroradiologists for evaluating acute stroke, according to research presented at the recent RSNA 2011 meeting in Chicago. The iPad 2 was judged to be the better option, however.
December 13, 2011
2011 12 19 17 26 02 948 Ipad 70
Neoprobe licenses Alzheimer's agent
By AuntMinnie.com staff writers
Radiopharmaceutical developer Neoprobe has secured worldwide exclusive rights from pharmaceutical firm AstraZeneca for its AZD4694 late-stage radiopharmaceutical imaging agent, which is used to help diagnose Alzheimer's disease.
December 12, 2011
Toshiba joins Steris for hybrid surgical suites
By AuntMinnie.com staff writers
Toshiba America Medical Systems has formed an alliance with surgical products provider Steris to offer vascular, cardiovascular, pediatric, and neurosurgical hybrid surgical suites.
December 12, 2011
MRI predicts decline from Parkinson's
By AuntMinnie.com staff writers
MRI's ability to determine brain atrophy patterns in patients with Alzheimer's disease also can be used to measure cognitive decline associated with Parkinson's disease, according to a study published online in Brain.
December 12, 2011
Prana gets OK for Alzheimer's trial
By AuntMinnie.com staff writers
Australian drug developer Prana Biotechnology has received approval from the Australian Austin Health Human Research Ethics Committee to begin a phase II imaging trial to evaluate its PBT2 drug for treating Alzheimer's disease.
December 5, 2011
Previous Page
Page 170 of 239
Next Page